Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs
"From what we know, rare diseases get a special, better treatment and are excluded from any tariffs," Chief Executive Robert Koremans said during a conference call on the pharmaceutical company's first-half results.
"It seems to be manageable," he added, referring to the potential impact of the U.S. measures on the company's results.
Treatments for rare diseases are an important part of Recordati's business, contributing revenues of 515.7 million euros in the first half of 2025.
Under a framework trade deal announced between U.S. President Donald Trump and the European Union on Sunday, the White House says EU pharmaceuticals will be subject to 15% tariffs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
4 minutes ago
- Daily Mail
DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms
The life sciences industry is among the brightest jewels in the British economy, generating £100billion a year and employing more than 300,000 people. At its heart is the development and manufacture of pharmaceuticals, notably by AstraZeneca, which spends vast sums on research and is worth £167billion. So, if this hugely successful company were to relocate to the US, it would be a disaster both for the London Stock Exchange and the wider economy. Worryingly, this is not out of the question. AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ramping up research and production there. While there are no immediate plans to desert the UK, chief executive Pascal Soriot is said to be 'flirting' with the idea. Mr Trump's latest demand that foreign drug companies cut prices to US customers or face penalties may be an added incentive. The Left has always been highly critical of 'Big Pharma', accusing it of profiteering on the backs of NHS patients. Under Jeremy Corbyn, Labour planned to create a state-owned drug manufacturer with the power to override the patents which enable firms to make profits from their research. Only last year, Sir Keir Starmer refused to help fund a new vaccine plant in Liverpool – while pouring public money into our ailing steel industry. This Government must understand that failing to nurture AstraZeneca, GSK and others would be a catastrophic mistake. And Sir Keir should realise that while they say they want to remain in the UK, they may yet change their mind. Car lenders off hook Banks and credit providers will have heaved a huge sigh of relief yesterday after the Supreme Court ruled they will not have to pay compensation to millions of motorists who bought cars on finance without being told the dealers were receiving commission on the loan. The Treasury was also delighted with the result. Had it gone the other way, damages could have been comparable to the PPI scandal, which destabilised the financial industry for more than a decade. The court decided that dealers did not have a duty to act solely for buyers and that commissions were not a form of bribery in the legal sense, as had been alleged. However, it was not a total exoneration. Court President Lord Reed also ruled that excessive commission payments were unfair and ordered one buyer who had been charged 25 per cent of the value of the car to be repaid with interest. This opens the way to further claims. Many brokers and dealers were paid behind-the-scenes commission by lenders to sign buyers up to car finance deals, a practice deemed 'unlawful' by the Court of Appeal in October last year - a decision that was successfully appealed by lenders at the Supreme Court The dealers and lenders have escaped their worst fears, but they do not come out well. They have certainly been guilty of sharp practices even if not illegal ones. The Competition and Markets Authority must now force them to clean up their act. OAPs feel the cold In September, Rachel Reeves promised she would 'put more money in pensioners' pockets'. What she didn't say is that she would take even more out. Research shows pensioner households are an average of £800 worse off after a year of Labour thanks to higher bills – mainly owing to the Chancellor's £40billion Budget tax raid. With more taxes coming down the track to fill Labour's ever-widening financial black hole, the cost of living is set to soar further. For all Ms Reeves' promises, the elderly are in for a bitter winter.
Reuters
34 minutes ago
- Reuters
Trump says Brazil's Lula can call him anytime
WASHINGTON/BRASILIA, Aug 1 (Reuters) - U.S. President Donald Trump said on Friday that Brazilian President Luiz Inacio Lula da Silva can call him anytime to discuss tariffs and other friction between the countries. "He can talk to me anytime he wants," Trump said of Lula, speaking to reporters at the White House. He added he was fond of the Brazilian people but "the people running Brazil did the wrong thing." Later, speaking with reporters in Brasilia, Brazil Finance Minister Fernando Haddad called Trump's remarks "great," saying he is sure Lula feels the same, and would be willing to receive a call from the U.S. president. In a post on his X account, Lula said Brazil has always been open to dialogue, although he did not mention Trump nor his earlier remarks. Trump slapped a 50% tariff on Brazil, with many exemptions, starting next week to fight what he has called a "witch hunt" against former President Jair Bolsonaro, who is on trial on charges of plotting a coup following his election loss in 2022. The U.S. also announced sanctions on a Brazilian Supreme Court justice who has been overseeing Bolsonaro's trial. Lula has rejected both the sanctions and the tariffs, calling them "unjustifiable" and an "unacceptable" interference in Brazil's justice system. Haddad said his planned virtual meeting with U.S. Treasury Secretary Scott Bessent next week will pave the way for an eventual meeting between Lula and Trump, but noted such a move would require preparation. Earlier this week, Haddad said Brazil needed assurance Lula would not face the same treatment as Ukraine's Volodymyr Zelenskiy, who came under fire from Trump and Vice President JD Vance during a heated exchange at the White House earlier this year.
Daily Mail
34 minutes ago
- Daily Mail
Heston Blumenthal reveals he's taking weight-loss drug Wegovy and shares fears that slimming jabs could pose a threat to the food industry
Heston Blumenthal has revealed he's taking the weight-loss drug Wegovy. The celebrity chef, 59, told how he's been taking the slimming aid to help combat the effects of his bipolar medication, having been diagnosed with type 1 bipolar in 2023. Heston also expressed his fears that the rise in popularity of weight loss jabs could pose a threat to the food industry. Speaking to Times Radio, Heston explained: 'I've put on so much weight, but it's starting to come off now', before adding that his use of the drug is a 'paradox' given the fact he's a restaurateur. The TV personality remarked how he'd lost 'eight kilos' on Wegovy so far, however, he has also dealt with side effects including brain fog, slurred speech and problems with balance. The drugs contain semaglutide, an amino acid, which suppresses appetite by mimicking a hormone telling the brain you are full up. In a new interview, the celebrity chef, 59, told how he's been taking the slimming aid to help combat the effects of his bipolar medication, having been diagnosed with type 1 bipolar back in 2023 [Boxes of Wegovy pictured] Heston issued a warning to the food industry, remarking how the continued use of the popular slimming jabs could have a detrimental affect on it. He explained: 'Wegovy, Ozempic, Mounjaro – you still enjoy food, but it stops appetite, so what's going to happen is people are going to want smaller portions.' Heston added that things were 'going to get much worse in the next six months' for restaurants, before expressing that supermarkets would also be affected. However, the food writer noted that he's 'formulating a plan' in a bid to help the food industry. Elsewhere, last month, Heston revealed he 'had thought about different ways of ending [his life]' before eventually receiving treatment for bipolar disorder. The London-born celebrity chef, who holds a total of seven Michelin stars across his restaurants, was diagnosed with type 1 bipolar after being sectioned - on the insistence of his wife, French entrepreneur Melanie Ceysson - in November 2023. Bipolar disorder is a brain disorder which causes unusual and often sudden changes in mood and energy levels. He spent two weeks heavily medicated in a psychiatric hospital and a further six weeks in a clinic, where he continued with intensive treatment and practised walking meditation. Yet, four years previously, he had already hit rock bottom and was contemplating the method he would use to take his own life. Looking back to filming the cookery show Crazy Delicious in 2019, Heston told The Times: 'I remember lying on the sofa the night before I was due to go to do the show - I didn't want to do it, because of the condition I was in - and I had thought about different ways of finishing [my life]. 'I went through a list: knife? No, can't do that. Gun? Don't have one. Rope? I don't think I could do that; wouldn't know how. It would probably slip off or whatever. 'And there was no train station anywhere near to jump in front of a train.' The father-of-four, whose first eatery, The Fat Duck, was named the best restaurant in the world in 2005, added that he didn't perceive that he was in a depressive state - even when he 'was talking about suicide or death'. He told the publication: 'I must have been in a mixed state [a period of rapid highs and lows], because I was excited about planning my funeral, planning my wake. What music I wanted, who I wanted there - I got quite excited about that.'
